Details of the Drug
General Information of Drug (ID: DM4KP5M)
Drug Name |
8-(2,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
8-(2,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine; 1H-Purine-2,6-diamine, 8-(3,4,5-trimethoxyphenyl)-; CHEMBL105523; 194613-10-0; 8-(2,4,5-trimethoxyphenyl)-3h-purine-2,6-diamine; 2,6-Diamino-8-(2',4',5'-trimethoxyphenyl)purine; AC1Q4FDE; AC1LAR90; CTK4E1570; DTXSID40173101; BDBM50059923; AKOS030559902; 8-(2,4,5-trimethoxyphenyl)-7H-purine-2,6-diamine
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 316.32 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 1 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 3 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 8 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References